Efficacy and safety of eplerenone, a navel and selective aldosterone receptor antagonist (SARA), in patients with mild to moderate hypertension

被引：0
|
作者：
Epstein, M
Alexander, JC
Roniker, B
机构：
[1] Univ Miami, Sch Med, Dept Med, Miami, FL USA
[2] Searle, Skokie, IL USA
来源：
HYPERTENSION | 1999年 / 33卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：1277 / 1277
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension
    Karlberg, BE
    Lins, LE
    Hermansson, K
    JOURNAL OF HYPERTENSION, 1999, 17 (02) : 293 - 302
  • [42] Addition of the selective aldosterone receptor antagonist eplerenone to ACE inhibition in heart failure:: effect on endothelial dysfunction
    Schäfer, A
    Fraccarollo, D
    Hildemann, SK
    Tas, P
    Ertl, G
    Bauersachs, J
    CARDIOVASCULAR RESEARCH, 2003, 58 (03) : 655 - 662
  • [43] Efficacy and safety of mineralocorticoid receptors in mild to moderate arterial hypertension
    Pelliccia, Francesco
    Rosano, Giuseppe
    Patti, Giuseppe
    Volterrani, Maurizio
    Greco, Cesare
    Gaudio, Carlo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 200 : 8 - 11
  • [44] EVALUATION OF THE SAFETY AND EFFICACY OF ENALAPRIL IN MILD-TO-MODERATE HYPERTENSION
    KOHAN, R
    GOREN, Y
    FRAJEWICKI, V
    RUDOY, Y
    LEIBA, M
    BENARI, J
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1988, 43 (03): : 355 - 360
  • [45] COMPARATIVE EFFICACY AND SAFETY OF LABETALOL AND METOPROLOL IN MILD TO MODERATE HYPERTENSION
    JOHNSON, B
    MICHELSON, EL
    FRISHMAN, WH
    POLAND, M
    SAWIN, HS
    KLEIN, N
    TORBUSH, S
    KREITZER, S
    JOHNSON, J
    BRADY, P
    MORGANROTH, J
    DREIFUS, LS
    SONNENBLICK, EH
    CLINICAL RESEARCH, 1982, 30 (02): : A633 - A633
  • [46] The selective aldosterone blocker eplerenone is superior to losartan in patients with low-renin hypertension
    Ruilope, LM
    Luque-Otero, M
    Plouin, P
    Fillastre, JP
    MacDonald, TM
    Roniker, B
    Patrick, JL
    Krause, S
    JOURNAL OF HYPERTENSION, 2002, 20 : S169 - S169
  • [47] Efficacy and Safety of Olmesartan in the Treatment of Mild-to-Moderate Essential Hypertension in Chinese Patients
    Chiau-Suong Liau
    Chii-Ming Lee
    Sheng-Hsiung Sheu
    Kwo-Chang Ueng
    Kuo-Liong Chien
    Ta-Chen Su
    Wen-Ter Lai
    Ming-Cheng Lin
    Cheng-Sheng Lin
    Chung-Sheng Lin
    Clinical Drug Investigation, 2005, 25 : 473 - 479
  • [48] Efficacy and safety of olmesartan in the treatment of mild-to-moderate essential hypertension in Chinese patients
    Liau, CS
    Lee, CM
    Sheu, SH
    Ueng, KC
    Chien, KL
    Su, TC
    Lai, WT
    Lin, MC
    Lin, CS
    Lin, CS
    CLINICAL DRUG INVESTIGATION, 2005, 25 (07) : 473 - 479
  • [49] Oral sitaxsentan, an endothelin-A selective receptor antagonist, reduces systemic blood pressure in patients with mild-to-moderate primary hypertension
    Calhoun, DA
    Renfroe, K
    Alper, AB
    CIRCULATION, 2000, 102 (18) : 417 - 417
  • [50] Effects of eplerenone, a selective mineralocorticoid receptor antagonist, on clinical and experimental salt-sensitive hypertension
    Takeda, Yoshiyu
    HYPERTENSION RESEARCH, 2009, 32 (05) : 321 - 324
12345